EMCDDA-Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone)
Salvato in:
European Monitoring Centre for Drugs and Drug Addiction, Europol, EMCDDA-Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone). Lisboa, European Monitoring Centre for Drugs and Drug Addiction, 2014, 54 p.
Ref.
196023
Localizzazione:
SIIS Archivo
Palabras clave:
Acción contra las drogodependencias, Control, Detección, Drogas ilegales, Drogodependencias, Efectos, Enfermedad, Evaluación, Factor de riesgo, Impacto social, Riesgo, Salud
Acción contra las drogodependencias, Control, Detección, Drogas ilegales, Drogodependencias, Efectos, Enfermedad, Evaluación, Factor de riesgo, Impacto social, Riesgo, Salud
Documenti analoghi: EMCDDA-Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone)
- EMCDDA-Europol Joint Report on a new psychoactive substance: AH-7921 (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide)
- EMCDDA-Europol Joint Report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone)
- EMCDDA-Europol Joint Report on a new psychoactive substance: 25I-NBOMe (4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine)
- EMCDDA–Europol Joint Report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’)
- EMCDDA-Europol Joint Report on a new psychoactive substance: 4,4'-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine)
- EMCDDA-Europol Joint Report on a new psychoactive substance: 5-(2-aminopropyl)indole. In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances